[Ultra-long-term follow-up of renal denervation in patients with resistant hypertension and mild chronic kidney disease].

作者：Li Wang, Hong Zhang, Chunjie Li, Xiaomeng Yin, Z Q Li, Qiang He, Xin Sun, Dasheng Xia, D L Kong, Chunlei Lu · 发表于：PubMed · 年份：2025 · DOI：10.3760/cma.j.cn112148-20250721-00521 · 研究领域：Chronic Kidney Disease and Diabetes、Blood Pressure and Hypertension Studies、Dialysis and Renal Disease Management

RDN demonstrates sustained antihypertensive efficacy with favorable renal safety in rHTN patients with mild CKD. Patients with higher baseline systolic blood pressure may exhibit better responsiveness to RDN.